Zeng Xiong, Ju Zhinan, Min Xixi, Zeng Xiande, Chen Wei, Dai Kanghui, Zhou Weimin, Qiu Jiehua
Department of Vascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Department of Vascular Surgery, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Front Cardiovasc Med. 2024 Dec 4;11:1401929. doi: 10.3389/fcvm.2024.1401929. eCollection 2024.
The risk of limb graft occlusion (LGO) after endovascular aneurysm repair (EVAR) is increased by severe tortuosity of the iliac artery. A bare metal stent (BMS) may protect LGO, according to the hypothesis of this single-center retrospective analysis.
All patients undergoing elective EVAR with a bifurcated stent graft between January 2012 and June 2022 were included in this cohort study. Patients demonstrating significant tortuosity at the iliac angle were incorporated into this study and classified into two groups: group A comprised those who received a BMS. In contrast, group B consisted of those who did not receive a BMS. The primary outcomes were the incidence of limb occlusion and technical success during the follow-up period. However, secondary outcomes included perioperative mortality, external iliac angioplasty, and crossed-limb techniques.
This study has been reported as being in line with the STROCSS criteria.
A total of 157 patients (mean age = 71.6 ± 8 years) with infrarenal abdominal aortic aneurysms were enrolled. In total, 50 individuals were included in group A, while 107 were in group B. Overall technical success was 100%, and only one (2%) patient from group A and 17 (15%) from group B suffered from limb occlusion during follow-up ( < 0.05). At a mean follow-up imaging duration of 28.7 ± 23.6 months (range 1-124), the estimated primary limb patency at 2 years was 98% for the BMS group and 84% for the non-BMS group ( < 0.05). There were no changes in perioperative mortality or crossed-limb procedures between the BMS and non-BMS groups. Nonetheless, there were disparities in external iliac angioplasty between the two groups during the follow-up period ( < 0.05).
Deploying a BMS inside the iliac artery to prevent or treat limb occlusion is a safe and effective strategy, with clear prolonged outcomes concerning patency and re-interventions.
髂动脉严重迂曲会增加血管内动脉瘤修复术(EVAR)后肢体移植物闭塞(LGO)的风险。根据这项单中心回顾性分析的假设,裸金属支架(BMS)可能会预防LGO。
本队列研究纳入了2012年1月至2022年6月期间所有接受分叉型支架移植物选择性EVAR的患者。在髂动脉角度显示出明显迂曲的患者被纳入本研究,并分为两组:A组包括接受BMS的患者。相比之下,B组由未接受BMS的患者组成。主要结局是随访期间肢体闭塞的发生率和技术成功率。然而,次要结局包括围手术期死亡率、髂外血管成形术和交叉肢体技术。
本研究已报告符合STROCSS标准。
总共纳入了157例(平均年龄=71.6±8岁)肾下腹主动脉瘤患者。A组共纳入50例,B组107例。总体技术成功率为100%,随访期间A组仅有1例(2%)患者和B组17例(15%)患者发生肢体闭塞(P<0.05)。在平均随访影像时间28.7±23.6个月(范围1-124个月)时,BMS组2年时的估计主要肢体通畅率为98%,非BMS组为84%(P<0.05)。BMS组和非BMS组之间围手术期死亡率或交叉肢体手术无变化。尽管如此,随访期间两组在髂外血管成形术方面存在差异(P<0.05)。
在髂动脉内植入BMS以预防或治疗肢体闭塞是一种安全有效的策略,在通畅率和再次干预方面有明显的长期效果。